PainChek General Discussion, page-6815

So this discussion is the whole reason I'm interested in the specifics of the patent, the tech and the nViso relationship. We've stumbled onto the early days of a whole new world in integrating AI in our daily lives. The applications are limitless, the outcome is to cut human error out where possible.

Everyone should have a good read through the Philips website, integration of AI in healthcare is a matter of when not if.

The non-verbal dementia & infant market is huge. But if we are positioned to capitalize on the whole market opportunity, then it's not a mini-cochlear, it's far bigger.
Hence my queries about the specifics about what exactly we have protected - the announcements are not all that clear on this. Imagine if we hold the tech that gets integrated in hospital rooms, A+E waiting rooms, GP waiting rooms, daycare centers, maternity suites......the list is endless.
So whats protected??

I was delighted to hear and looking forward to reading the case study of the patient in NZ that spoke for the first time in 4 years, that's a pretty incredible real-life result. Based on that outcome alone its hard to deny the benefit of Painchek or AI in healthcare. Life-changing for the patient, his family and his carers for $60/year.